Characteristics

Stanozolol THP is the same compound as the illegal anabolic steroid stanozolol (Winstrol) except it is not 17aa methylated, and instead has a THP ether attached on the 17b position. 

The conversion rate for this compound is very low, expected to be less than 15%.  Knowing this, users are better off taking doses in the 150-250mg range.  The downfall to this is the high cost.

Stanozolol THP does not aromatize and also has very minimal bloat. It has a moderately potent androgenic activity, giving it a fairly low risk for gyno or negative effects on the libido. However its androgenic effects may pose a problem for users prone to androgenic related hair loss. 

Once the Stanozolol THP reaches the stomach, most of the THP-ether is probably removed by the stomach acid to form stanozolol (the non-methylated version). Therefore, topical delivery of this compound is probably not worthwhile. 

Overall this compound produces mild gains, but the side-effects are very mild too. Noticeable gains in lean muscle mass and strength are not likely going to be achieved unless doses of at least 200mg/day are used. Stanozolol THP is going to produce very little water retention, therefore it should produce a lean and vascular appearance. Big increases in weight are not likely to happen with this steroid either, so increased blood pressure and painful back pumps should not be a problem.

This compound would work well for cutting cycles and would stack well almost any other steroid depending on the goals.

Common Clones:

WinZstrol by Juggarnaught Nutrition
Prostanzonol by Juggarnaught Nutrition
Prostanozol by Generic Labs
Prostanozol by Anabolic Xtreme
P-Stanz by Competitive Edge Labs (CEL)
Orastan-E by Gaspari Nutrition

Related Discussion

The Official Stanozolol THP Thread
Posted by Eric

References

“Metabolism and excretion of anabolic steroids in doping control—New steroids and new insights”

Peter Van Eenoo and Frans T. Delbeke

The Journal of Steroid Biochemistry and Molecular Biology; Volume 101, Issues 4-5, November 
2006, Pages 161-178